CAS 435293-66-6

Phenol,3-methyl-4-[(1R)-3-(methylamino)-1-phenylpropoxy]-

Description:

Phenol, 3-methyl-4-[(1R)-3-(methylamino)-1-phenylpropoxy]- is a chemical compound characterized by its complex structure, which includes a phenolic group and an alkyl chain with a methylamino substituent. This compound typically exhibits properties associated with both phenols and amines, such as moderate solubility in organic solvents and potential hydrogen bonding capabilities due to the hydroxyl group. The presence of the methylamino group suggests that it may exhibit basic properties, allowing it to participate in various chemical reactions, including nucleophilic substitutions. Additionally, the specific stereochemistry indicated by the (1R) configuration may influence its biological activity and interaction with other molecules. This compound may be of interest in pharmaceutical research, particularly in the development of drugs targeting specific biological pathways. Its unique structure could also lead to specific pharmacokinetic and pharmacodynamic properties, making it a candidate for further investigation in medicinal chemistry.

Formula: C₁₇H₂₁NO₂

Synonyms:

• 4-Hydroxyatomoxetine

4-hydroxy Atomoxetine

CAS: 435293-66-6

Formula: C₁₇H₂₁NO₂

Purity: 97.04%

Color and Shape: Solid

Molecular weight: 271.3541

Ref: IN-DA00DFBN

4-Hydroxyatomoxetine

CAS: 435293-66-6

4-Hydroxyatomoxetine

Purity: ≥95%

Molecular weight: 271.36g/mol

Ref: 54-OR1075517

4’-Hydroxy Atomoxetine

Controlled Product

CAS: 435293-66-6

Formula: C₁₇H₂₁NO₂

Color and Shape: Fluid

Molecular weight: 271.35

Ref: TR-H802500

4-Hydroxyatomoxetine

CAS: 435293-66-6

Purity: 97%

Molecular weight: 271.3599854

Ref: 10-F606737

4'-Hydroxy atomoxetine

CAS: 435293-66-6

4'-Hydroxyatomoxetine is a metabolite of atomoxetine, which is a drug that is used to treat attention deficit hyperactivity disorder and narcolepsy. 4'-Hydroxyatomoxetine has been shown to have pharmacological properties similar to those of atomoxetine. However, it does not bind to the κ-opioid receptors, unlike its parent drug. The analytical method for this metabolite has been developed using liquid chromatography with tandem mass spectrometry. The major limitation with the analytical method is that it can be affected by matrix effects and hepatic impairment. This metabolite is glucuronidated and then conjugated with trifluoroacetic acid (TFA) before excretion in urine or bile. It also binds to kappa-opioid receptors, but at a lower affinity than its parent compound.

Formula: C₁₇H₂₁NO₂

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 271.35 g/mol

Ref: 3D-FH23905

4-Hydroxy Atomoxetine

CAS: 435293-66-6

Formula: C₁₇H₂₁NO₂

Molecular weight: 271.36

Ref: ST-EA-CP-A30023

4-Hydroxyatomoxetine

CAS: 435293-66-6

4-Hydroxyatomoxetine, an active metabolite of Atomoxetine, is metabolized by CYP2D6. Atomoxetine is a noradrenaline reuptake inhibitor.

Formula: C₁₇H₂₁NO₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 271.35

Ref: TM-T10145